mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.083 |
0.03 |
mRNA |
GDC-0879 |
CTRPv2 |
pan-cancer |
AAC |
-0.081 |
0.03 |
mRNA |
MI-1 |
CTRPv2 |
pan-cancer |
AAC |
0.09 |
0.03 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.081 |
0.03 |
mRNA |
BRD-K16130065 |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
0.03 |
mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.081 |
0.03 |
mRNA |
erastin |
CTRPv2 |
pan-cancer |
AAC |
0.08 |
0.03 |
mRNA |
Docetaxel |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.03 |
mRNA |
BMS-754807 |
CTRPv2 |
pan-cancer |
AAC |
-0.078 |
0.03 |
mRNA |
BRD-K33199242 |
CTRPv2 |
pan-cancer |
AAC |
-0.084 |
0.04 |